The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteins.
Kumar S, Jain S, Wali B, Zarnitsyna VI, Joshi D, Ellis ML, Lai L, Malik AA, McPherson TO, Godbole S, Patel A, Linderman S, Solis D, Sahoo MK, Bechnak K, Paredes I, Tanios R, Kazzi B, Dib SM, Litvack MB, Wimalasena ST, Hicks H, Tamin A, Bowen NE, Atherton L, Paden C, Harcourt JL, Wentworth DE, Ciric C, West RH, Rostad CA, Teng IT, Wang D, Ortlund EA, Menachery VD, Edupuganti S, Kwong PD, Rouphael N, Pinsky BA, Douek DC, Moreno A, Wrammert J, Suthar MS.
Kumar S, et al. Among authors: ellis ml.
Sci Transl Med. 2025 Sep 3;17(814):eadu8067. doi: 10.1126/scitranslmed.adu8067. Epub 2025 Sep 3.
Sci Transl Med. 2025.
PMID: 40901926